ALS Society of Canada

Jan 14, 2020

ALS Association Makes Multi-Year Commitment to HEALEY ALS Platform Trial

Dec 04, 2019

New ALS Association Partnership with ALS Investment Fund Targets $100 Million in New Funding for ALS Therapeutic Development

Nov 28, 2018

ALS Organizations Collaborate to Advance New Therapeutic into Trials

Oct 04, 2018

Mitsubishi Tanabe Pharma Canada Announces Canadian Authorization of Radicava(TM) (Edaravone) to Treat ALS

May 04, 2018

MDA And ALS ONE Form New Partnership To Accelerate ALS Biomarker Research

May 01, 2018

The ALS Association Calls on Advocates to 'Raise Your Voice' During ALS Awareness Month

Apr 09, 2018

Health Canada Accepts Mitsubishi Tanabe Pharma Corporation's NDS Filing for Edaravone to Treat ALS, Grants Priority Review

Dec 07, 2017

Balas Begins Role as President and CEO of ALS Association

Dec 07, 2017

Balas Begins Role as President and CEO of ALS Association

Nov 22, 2017

ALS Canada awards $3 million for 12 new research projects to help make amyotrophic lateral sclerosis (ALS) a treatable, not terminal disease

Jun 01, 2017

Making ALS a treatable, not terminal disease